𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming Growth Factor (TGF)-β1 Releasing Tricalcium Phosphate/Chitosan Microgranules as Bone Substitutes

✍ Scribed by Jue-Yeon Lee; Yang-Jo Seol; Kyoung-Hwa Kim; Yong-Moo Lee; Yoon-Jeong Park; In-Chul Rhyu; Chong-Pyoung Chung; Seung-Jin Lee

Book ID
111603720
Publisher
Springer US
Year
2004
Tongue
English
Weight
298 KB
Volume
21
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced bone formation by transforming
Enhanced bone formation by transforming growth factor-β1-releasing collagen/chitosan microgranules
✍ Jue-Yeon Lee; Kyoung-Hwa Kim; Seung-Yoon Shin; In-Chul Rhyu; Yong-Moo Lee; Yoon- 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

## Abstract Collagen/chitosan composite microgranules were fabricated as bone substitutes for the purpose of obtaining high bone‐forming efficacy. The microgranules have the flexibility to fill various types of defect sites with closer packing. The interconnected pores formed spaces between the mic

Transforming growth factor-β1 enhances b
Transforming growth factor-β1 enhances bone healing to unloaded tricalcium phosphate coated implants: An experimental study in dogs
✍ Martin Lind; Søren Overgaard; Kjeld Søballe; Tue Nguyen; Boonsri Ongpipattanakul 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 891 KB

## Abstract Growth of bone into cementless prosthetic components is compromised after revision of failed joint prostheses and by osteoporosis, gaps, and micromotion. We studied the effects of recombinant human transforming growth factor‐β1 adsorbed on ceramic coated implants on the improvement of m

Development of tricalcium phosphate/amyl
Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler
✍ Ongpipattanakul, Boonsri ;Nguyen, Tue ;Zioncheck, Thomas F. ;Wong, Rita ;Osaka, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Tricalcium phosphate (TCP) was combined with that the model used was not a critical defect may account amylopectin to form a deliverable carrier paste for recombi-for the lack of superiority of the rhTGF-␤ 1 -treated group over nant human transforming growth factor ␤ 1 (rhTGF-␤ 1 ) in-the healing of